Development of a mutation profiling NGS assay to facilitate clinical decisions in hematologic malignancies | Labcorp Oncology Skip to main contentScroll Back to Top
Development of a mutation profiling NGS assay to facilitate clinical decisions in hematologic malignancies
Poster
Development of a mutation profiling NGS assay to facilitate clinical decisions in hematologic malignancies
Grant Hogg, Tong Liu, Helen Cao, Adib Shafi, Ashraf Shabaneh, John Howitt, Amanda Williamson, Rachel Dango, Xiaojun Guan, Heidi Hoffmann, Michael Mooney, John Pruitt, Scott Parker, Stan Letovsky, Li Cai, Eric A Severson, Shakti Ramkissoon, Anjen Chenn, Marcia Eisenberg, Eyad Almasri, and Taylor J. Jensen.